Walleye Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Walleye Capital’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-80,198	Closed	-$1.26M	–	3749
2022 Q2	$1.26M	Buy	80,198 +9,324	+13%	+$142K	0.03%	536
2022 Q1	$1.08M	Sell	70,874 -19,373	-21%	-$295K	0.03%	604
2021 Q4	$1.39M	Buy	+90,247	New	+$1.19M	0.04%	433
2020 Q2	–	Sell	-1,000	Closed	-$7K	–	1083
2020 Q1	$7K	Buy	+1,000	New	+$7.41K	﹤0.01%	800
2019 Q2	–	Sell	-14,124	Closed	-$89K	–	2171
2019 Q1	$89K	Buy	+14,124	New	+$99K	0.01%	1073

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Walleye Capital's NPTN Position: Q3 2022 in Review

Walleye Capital sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 80,198 shares — an estimated $1.26M sold.

Walleye Capital first reported a position in NPTN in Q1 2019 and held it in 5 quarters. The position peaked at $1.39M in Q4 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Walleye Capital reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Walleye Capital sold 80,198 NEOPHOTONICS CORP shares in Q3 2022, an estimated $1.26M.
Walleye Capital first reported a position in NEOPHOTONICS CORP in Q1 2019 and held it in 5 quarters.
Walleye Capital's NEOPHOTONICS CORP position peaked at $1.39M in Q4 2021.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Walleye Capital's 13F filing for Q3 2022, filed 14 Nov 2022.